RecruitingNCT07061509

Exercise Addiction and Health Risks in Gym Users

Musculoskeletal and Cardiovascular Effects of Exercise Addiction in Recreational Bodybuilders


Sponsor

Saglik Bilimleri Universitesi

Enrollment

32 participants

Start Date

Jul 29, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study aims to investigate the prevalence of musculoskeletal injuries and cardiovascular risk factors among individuals with and without exercise addiction. Adult recreational gym users who have been engaging in resistance training for at least six months will be included. Participants will be divided into two groups based on their exercise dependence levels, and outcomes such as musculoskeletal symptoms, anabolic substance use, and cardiovascular risk scores will be compared between groups.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Battery of Physical and Psychological Assessments for people with cardiovascular abnormalities and exercise addiction. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBattery of Physical and Psychological Assessments

Participants in this observational study will not receive any therapeutic intervention. Instead, all individuals will undergo a series of standardized non-invasive assessments for data collection purposes. These include the Exercise Dependence Scale-21 (EDS-21) to classify exercise addiction status, the Drive for Muscularity Scale (DMS) to evaluate body image and muscle-related attitudes, and the Extended Nordic Musculoskeletal Questionnaire to determine the presence and severity of musculoskeletal symptoms. Cardiovascular risk will be assessed using the SCORE Risk Assessment System, which incorporates blood pressure, cholesterol, blood glucose, smoking status, and demographic data. Additional measurements will include oxygen saturation and heart rate using pulse oximetry, and blood pressure using a sphygmomanometer. These evaluations are intended solely for comparative analysis between exercise-dependent and non-dependent groups.


Locations(1)

Esra Pehlivan

Istanbul, Üsküdar, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07061509


Related Trials